ÂÜÀòÂÒÂ×

Ben Wensley Stock is an accomplished professional with extensive experience in the medical technology field. Currently serving as Chief Technology Officer and Advisor to the Board at Syntrillo since February 2021, Ben specializes in stroke-related wellness and clinical decision support systems. Simultaneously, Ben holds roles as Expert in Residence for Medical Devices at the University of Oxford, Chief Executive Officer at MPS Medical-Product-Service UK Ltd, and Senior Managing Director at Cumulus Capital Partners, focusing on M&A and strategic advisory services. Ben also advises Oxehealth, where expertise in regulatory processes has streamlined quality standards, and provides regulatory consulting for gaitQ and Sēon Diagnostics Ltd. With a background in technology and regulatory affairs, Ben is the CEO of WENSLEY STOCK LIMITED, facilitating regulatory and technology services across healthcare and innovation domains. Ben’s educational background includes a Master of Philosophy in Spatial Analysis from Cranfield Institute and a degree from The University of Manchester.